Cargando…

Immunogenic cell death in radiation therapy

Detalles Bibliográficos
Autores principales:	Galluzzi, Lorenzo, Kepp, Oliver, Kroemer, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Editor's Corner
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881599/ https://www.ncbi.nlm.nih.gov/pubmed/24404424 http://dx.doi.org/10.4161/onci.26536

Ejemplares similares

Immunogenic cell death in cancer: concept and therapeutic implications
por: Galluzzi, Lorenzo, et al.
Publicado: (2023)

Detection of immunogenic cell death and its relevance for cancer therapy
por: Fucikova, Jitka, et al.
Publicado: (2020)

Mitochondrial regulation of cell death: a phylogenetically conserved control
por: Galluzzi, Lorenzo, et al.
Publicado: (2016)

Rejuvenated T cells attack old tumors
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Combinatorial Strategies for the Induction of Immunogenic Cell Death
por: Bezu, Lucillia, et al.
Publicado: (2015)

Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014)

A novel platinum-based chemotherapeutic inducing immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2020)

Corrigendum: “Combinatorial Strategies for the Induction of Immunogenic Cell Death”
por: Bezu, Lucillia, et al.
Publicado: (2015)

Immunogenicity of cell death driven by immune effectors
por: Galluzzi, Lorenzo, et al.
Publicado: (2020)

Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
por: Gomes-da-Silva, Lígia C., et al.
Publicado: (2020)

Cancer immunotherapy turns viral
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Abscopal but desirable: The contribution of immune responses to the efficacy of radiotherapy
por: Kroemer, Guido, et al.
Publicado: (2012)

Can the exome and the immunome converge on the design of efficient cancer vaccines?
por: Kroemer, Guido, et al.
Publicado: (2012)

Targeting PD-1/PD-L1 interactions for cancer immunotherapy
por: Zitvogel, Laurence, et al.
Publicado: (2012)

Novel multifunctional antibody approved for the treatment of breast cancer
por: Mavilio, Domenico, et al.
Publicado: (2013)

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020)

Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers
por: Mariño, Guillermo, et al.
Publicado: (2014)

An unexpected link between immunogenic cell death and inhibition of gene transcription
por: Humeau, Juliette, et al.
Publicado: (2020)

The European Academy of Tumor Immunology: Bridging fields, continents and generations
por: Kroemer, Guido, et al.
Publicado: (2012)

Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
por: Sukkurwala, Abdul Qader, et al.
Publicado: (2014)

Immune effectors required for the therapeutic activity of vorinostat
por: Kepp, Oliver, et al.
Publicado: (2013)

TP53 and MTOR crosstalk to regulate cellular senescence
por: Galluzzi, Lorenzo, et al.
Publicado: (2010)

Functions of BCL-X(L) at the Interface between Cell Death and Metabolism
por: Michels, Judith, et al.
Publicado: (2013)

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

Small cell lung cancer responds to immunogenic chemotherapy followed by PD-1 blockade
por: Kroemer, Guido, et al.
Publicado: (2021)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2012)

Trial watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2013)

Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
por: Michaud, Mickaël, et al.
Publicado: (2014)

Cell Death Signaling and Anticancer Therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2011)

A mitochondrial checkpoint to adaptive anticancer immunity
por: Kepp, Oliver, et al.
Publicado: (2023)

Ferroptosis becomes immunogenic: implications for anticancer treatments
por: Tang, Daolin, et al.
Publicado: (2020)

Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus
por: Gomes-da-Silva, Lígia Catarina, et al.
Publicado: (2018)

Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors
por: Kroemer, Guido, et al.
Publicado: (2016)

Trial Watch: Chemotherapy with immunogenic cell death inducers
por: Vacchelli, Erika, et al.
Publicado: (2014)

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013)

Hormesis, cell death and aging
por: Martins, Isabelle, et al.
Publicado: (2011)

Telomeres in cancer therapy
por: Blasco, María A
Publicado: (2001)

Trial watch: Cardiac glycosides and cancer therapy
por: Menger, Laurie, et al.
Publicado: (2013)

Welcoming Paul Dent as Assistant Editor-in-Chief of Cancer Biology & Therapy
por: El-Deiry, Wafik S
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uf3bf76lee3h7jc7js8m2fflhv